Skip to main content
Clinical Trials/NCT00567645
NCT00567645
Withdrawn
Not Applicable

Identification of the Role of Sympathetic Innervation in Heart Failure Patients Treated With Cardiac Resynchronization Therapy. A Pilot Study

University Medical Center Groningen1 site in 1 countryJuly 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sympathetic Innervation
Sponsor
University Medical Center Groningen
Locations
1
Primary Endpoint
sympathetic innervation in patients with chronic heart failure (CHF)
Status
Withdrawn
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to assess whether baseline sympathetic innervation in patients with chronic heart failure (CHF) is predictive for response to cardiac resynchronization therapy (CRT). And to assess whether response to CRT coincides with restoration of regional sympathetic innervation.

Registry
clinicaltrials.gov
Start Date
July 2007
End Date
TBD
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

I.C. Van Gelder

Prof.dr.

University Medical Center Groningen

Eligibility Criteria

Inclusion Criteria

  • Indication for CRT
  • Stable optimal medication
  • Non ischemic cardiomyopathy

Exclusion Criteria

  • Age less then 18 years
  • Previous CRT
  • Clinically relevant valvular heart disease or coronary artery disease
  • Acute or chronic infection
  • Untreated clinical hypo- or hyperthyroidism or \< 3 months euthyroidism
  • Uncontrolled hypertension, defined as a systolic blood pressure \> 160 mm Hg and/or a diastolic blood pressure \> 95 mm Hg
  • A concurrent medical condition (i.e. alcohol or drug abuse or a severe progressive extra cardiac disease or M. Parkinson) or is unlikely to comply with the protocol
  • Participation to a previous protocol involving radioactivity in the past year
  • Pregnancy

Outcomes

Primary Outcomes

sympathetic innervation in patients with chronic heart failure (CHF)

Time Frame: 6 months

Secondary Outcomes

  • NYHA class Echocardiographic parameters: LVEDD, LVESD, LVEF, LVESV,IVMD, and septal to lateral delay Hospitalization for heart failure Maximal oxygen consumption NT pro-BNP changes(6 months)

Study Sites (1)

Loading locations...

Similar Trials